Myeloid-derived suppressors cells (MDSC) correlate with clinicopathologic factors and pathologic complete response (pCR) in patients with urothelial carcinoma (UC) undergoing cystectomy.

MLA

Ornstein, Moshe C., et al. “Myeloid-Derived Suppressors Cells (MDSC) Correlate with Clinicopathologic Factors and Pathologic Complete Response (PCR) in Patients with Urothelial Carcinoma (UC) Undergoing Cystectomy.” Urologic Oncology, vol. 36, no. 9, Sept. 2018, pp. 405–12. EBSCOhost, https://doi.org/10.1016/j.urolonc.2018.02.018.

APA

Ornstein, M. C., Diaz-Montero, C. M., Rayman, P., Elson, P., Haywood, S., Finke, J. H., Kim, J. S., Pavicic, P. G., Lamenza, M., Devonshire, S., Dann, P., Schach, K., Stephenson, A., Campbell, S., Emamekhoo, H., Ernstoff, M. S., Hoimes, C. J., Gilligan, T. D., Rini, B. I., & Garcia, J. A. (2018). Myeloid-derived suppressors cells (MDSC) correlate with clinicopathologic factors and pathologic complete response (pCR) in patients with urothelial carcinoma (UC) undergoing cystectomy. Urologic Oncology, 36(9), 405–412. https://doi.org/10.1016/j.urolonc.2018.02.018

Chicago

Ornstein, Moshe C., Claudia Marcela Diaz-Montero, Patricia Rayman, Paul Elson, Samuel Haywood, James H. Finke, Jin S. Kim, et al. 2018. “Myeloid-Derived Suppressors Cells (MDSC) Correlate with Clinicopathologic Factors and Pathologic Complete Response (PCR) in Patients with Urothelial Carcinoma (UC) Undergoing Cystectomy.” Urologic Oncology 36 (9): 405–12. doi:10.1016/j.urolonc.2018.02.018.